Performance of radiomics in the differential diagnosis of parotid tumors: a systematic review
Frontiers in Oncology · 25.07.2024 · 14
DOI: 10.3389/fonc.2024.1383323 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 25.07.2024. Verfasst von Yilin Rao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prosthodontics, The Affiliated Stomatology Hospital, Southwest Medical University, Luzhou, Sichuan, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
A systematic review and meta-analysis were conducted to evaluate the diagnostic precision of radiomics in the differential diagnosis of parotid tumors, considering the increasing utilization of radiomics in tumor diagnosis. Although some researchers have attempted to apply radiomics in this context, there is ongoing debate regarding its accuracy.
Methods
Databases of PubMed, Cochrane, EMBASE, and Web of Science up to May 29, 2024 were systematically searched. The quality of included primary studies was assessed using the Radiomics Quality Score (RQS) checklist. The meta-analysis was performed utilizing a bivariate mixed-effects model.
Results
A total of 39 primary studies were incorporated. The machine learning model relying on MRI radiomics for diagnosis malignant tumors of the parotid gland, demonstrated a sensitivity of 0.80 [95% CI: 0.74, 0.86], SROC of 0.89 [95% CI: 0.27-0.99] in the validation set. The machine learning model based on MRI radiomics for diagnosis malignant tumors of the parotid gland, exhibited a sensitivity of 0.83[95% CI: 0.76, 0.88], SROC of 0.89 [95% CI: 0.17-1.00] in the validation set. The models also demonstrated high predictive accuracy for benign lesions.
Conclusion
There is great potential for radiomics-based models to improve the accuracy of diagnosing benign and malignant tumors of the parotid gland. To further enhance this potential, future studies should consider implementing standardized radiomics-based features, adopting more robust feature selection methods, and utilizing advanced model development tools. These measures can significantly improve the diagnostic accuracy of artificial intelligence algorithms in distinguishing between benign and malignant tumors of the parotid gland. Systematic review registration https://www.crd.york.ac.uk/prospero/ , identifier CRD42023434931.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Prosthodontics, The Affiliated Stomatology Hospital, Southwest Medical University, Luzhou, Sichuan, China.
- Luzhou Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, Sichuan, China.
Zitieren
APA
Rao, Y., Ma, Y., Wang, J., Xiao, W., Wu, J., Shi, L., Guo, L., & Fan, L. (2024). Performance of radiomics in the differential diagnosis of parotid tumors: a systematic review. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1383323
Vancouver
Rao Y, Ma Y, Wang J, Xiao W, Wu J, Shi L, et al. Performance of radiomics in the differential diagnosis of parotid tumors: a systematic review. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1383323
BibTeX
@article{Rao2024,
author = {Rao, Yilin and Ma, Yuxi and Wang, Jinghan and Xiao, Weiwei and Wu, Jiaqi and Shi, Liang and Guo, Ling and Fan, Liyuan},
title = {Performance of radiomics in the differential diagnosis of parotid tumors: a systematic review},
journal = {Frontiers in Oncology},
year = {2024},
volume = {14},
doi = {10.3389/fonc.2024.1383323}
}
EUVIMED